A detailed history of Bare Financial Services, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bare Financial Services, Inc holds 96 shares of GILD stock, worth $11,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 84 14.29%
Holding current value
$11,912
Previous $9.31 Million 14.42%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$108.22 - $120.47 $1,298 - $1,445
12 Added 14.29%
96 $10.7 Million
Q2 2025

Aug 13, 2025

BUY
$96.91 - $113.0 $8,140 - $9,492
84 New
84 $9.31 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.